LUCA Science is at the forefront of a new kind of mitochondrial therapy that aims to restore cellular bioenergetics in malfunctioning or damaged tissues and organs. Using our patented iMIT technology, LUCA Science is creating a novel platform of highly functional mitochondria. We could boost bioenergetics and restore normal activities by supplyingintact and functional mitochondria to the affected tissues. The utilization of mitochondria as a biopharmaceutical agent would be groundbreaking for treating a wide range of unmet medical needs.

Biotechnology

Health Care

Pharmaceutical

LUCA Science Inc.

Rick C. Tsai

Yosuke Matsumiya

Yosuke M.

Hisashi Ohta

Tomoyuki Inoue

Yoshikazu Tokuoka

Masashi Suganuma

LUCA Science Inc.

Org chart

Similar companies